Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influvac 2012/2013 Season Immunogenicity and Safety
NCT01633749Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jul 2012
- Primary completion
- Jul 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of inactivated influenza vaccine (surface antigen) in influenza, sponsored by Abbott Laboratories. Started Jul 2012; status: completed.
02
Drugs
inactivated influenza vaccine (surface antigen)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01633749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01633749.